AR099035A1 - Derivado de 6-oxo-1,6-dihidro-piridazina para usar en el tratamiento de carcinoma de células renales (rcc) - Google Patents
Derivado de 6-oxo-1,6-dihidro-piridazina para usar en el tratamiento de carcinoma de células renales (rcc)Info
- Publication number
- AR099035A1 AR099035A1 ARP150100023A ARP150100023A AR099035A1 AR 099035 A1 AR099035 A1 AR 099035A1 AR P150100023 A ARP150100023 A AR P150100023A AR P150100023 A ARP150100023 A AR P150100023A AR 099035 A1 AR099035 A1 AR 099035A1
- Authority
- AR
- Argentina
- Prior art keywords
- rcc
- oxo
- treatment
- carcinoma
- piridazina
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title 1
- 208000006265 Renal cell carcinoma Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- AHYMHWXQRWRBKT-UHFFFAOYSA-N tepotinib Chemical compound C1CN(C)CCC1COC1=CN=C(C=2C=C(CN3C(C=CC(=N3)C=3C=C(C=CC=3)C#N)=O)C=CC=2)N=C1 AHYMHWXQRWRBKT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
3-(1-{3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)-benzonitrilo o una sal farmacéuticamente aceptable y/o solvato del mismo para usar Para el tratamiento de carcinoma de células renales (RCC).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14000036 | 2014-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR099035A1 true AR099035A1 (es) | 2016-06-22 |
Family
ID=49916969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150100023A AR099035A1 (es) | 2014-01-07 | 2015-01-07 | Derivado de 6-oxo-1,6-dihidro-piridazina para usar en el tratamiento de carcinoma de células renales (rcc) |
Country Status (17)
Country | Link |
---|---|
US (1) | US20160331748A1 (es) |
EP (1) | EP3091980A1 (es) |
JP (1) | JP2017502978A (es) |
KR (1) | KR20160099724A (es) |
CN (1) | CN105873591A (es) |
AR (1) | AR099035A1 (es) |
AU (1) | AU2014377079A1 (es) |
CA (1) | CA2935889C (es) |
CL (1) | CL2016001726A1 (es) |
IL (1) | IL246628A0 (es) |
MX (1) | MX2016008815A (es) |
MY (1) | MY191613A (es) |
PH (1) | PH12016500964A1 (es) |
RU (1) | RU2016132401A (es) |
SG (1) | SG11201605501RA (es) |
TW (1) | TW201609103A (es) |
WO (1) | WO2015104042A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3996688T (lt) * | 2019-07-10 | 2023-12-27 | Merck Patent Gmbh | Farmacinis preparatas |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007032507A1 (de) * | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
CA2949515C (en) * | 2009-01-08 | 2018-10-23 | Axel Becker | Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof |
-
2014
- 2014-12-16 KR KR1020167021524A patent/KR20160099724A/ko not_active Application Discontinuation
- 2014-12-16 AU AU2014377079A patent/AU2014377079A1/en not_active Abandoned
- 2014-12-16 EP EP14814775.4A patent/EP3091980A1/en not_active Withdrawn
- 2014-12-16 MY MYPI2016702444A patent/MY191613A/en unknown
- 2014-12-16 CN CN201480072413.9A patent/CN105873591A/zh active Pending
- 2014-12-16 CA CA2935889A patent/CA2935889C/en active Active
- 2014-12-16 SG SG11201605501RA patent/SG11201605501RA/en unknown
- 2014-12-16 RU RU2016132401A patent/RU2016132401A/ru unknown
- 2014-12-16 WO PCT/EP2014/003365 patent/WO2015104042A1/en active Application Filing
- 2014-12-16 JP JP2016544793A patent/JP2017502978A/ja active Pending
- 2014-12-16 MX MX2016008815A patent/MX2016008815A/es unknown
- 2014-12-16 US US15/110,174 patent/US20160331748A1/en not_active Abandoned
-
2015
- 2015-01-06 TW TW104100321A patent/TW201609103A/zh unknown
- 2015-01-07 AR ARP150100023A patent/AR099035A1/es unknown
-
2016
- 2016-05-24 PH PH12016500964A patent/PH12016500964A1/en unknown
- 2016-07-06 IL IL246628A patent/IL246628A0/en unknown
- 2016-07-06 CL CL2016001726A patent/CL2016001726A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW201609103A (zh) | 2016-03-16 |
EP3091980A1 (en) | 2016-11-16 |
IL246628A0 (en) | 2016-08-31 |
RU2016132401A (ru) | 2018-02-13 |
CN105873591A (zh) | 2016-08-17 |
MY191613A (en) | 2022-07-03 |
CA2935889A1 (en) | 2015-07-16 |
JP2017502978A (ja) | 2017-01-26 |
NZ722879A (en) | 2021-08-27 |
SG11201605501RA (en) | 2016-08-30 |
MX2016008815A (es) | 2016-09-08 |
CA2935889C (en) | 2022-08-16 |
US20160331748A1 (en) | 2016-11-17 |
KR20160099724A (ko) | 2016-08-22 |
AU2014377079A1 (en) | 2016-08-18 |
RU2016132401A3 (es) | 2018-08-29 |
CL2016001726A1 (es) | 2016-12-16 |
PH12016500964A1 (en) | 2016-06-20 |
WO2015104042A1 (en) | 2015-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20130649A (es) | Liberación modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida solubilizada utilizando ácidos orgánicos | |
MX371291B (es) | 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procedimientos para su preparacion. | |
TWD171049S (zh) | 硬碟機 | |
EA201390275A1 (ru) | Кристаллический (r)-(e)-2-(4-(2-(5-(1-(3,5-дихлорпиридин-4-ил)этокси)-1h-индазол-3-ил)винил)-1h-пиразол-1-ил)этанол | |
DK2373640T3 (da) | Hidtil ukendte polymorfe former af 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitril-hydrochloridsalt og fremgangsmåder til fremstilling deraf | |
CL2016002495A1 (es) | Derivados de piridina macrocíclicos . | |
DK3395342T3 (da) | Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf | |
CL2018000436A1 (es) | Alcoholes trifluorometílicos como moduladores de roryt (divisional solicitud 201701042). | |
DK3193594T3 (da) | Fremgangsmåder til frembringelse af cellebank med ultrahøj densitet | |
CO2017005544A2 (es) | Tableta multicapa que contiene fármaco inestable a la luz | |
DK3139940T3 (da) | Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi | |
UY34856A (es) | Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida | |
ZA201600021B (en) | 4-(5-(4-chlorophenyl)-2-(2-cyclopropylacetyl)-1,4-dimethyl-1h-pyrrol-3-yl)benzenesulfonamide as alpha 7 nachr modulator | |
MX2017005884A (es) | Metodos para el tratamiento de la erc, utilizando predictores de la retencion de liquidos. | |
CL2017001477A1 (es) | Combinación de un derivado de 6-oxo-1,6-dihidro-piridazina que tiene actividad anti-cáncer con un derivado de quinazolina | |
CL2017001478A1 (es) | Combinación de un derivado de 6-oxo-1,6-dihidro-piridazina que tiene actividad anti-cáncer con un inhibidor de factor de crecimiento epidérmico (egfr) | |
BR112015010121A2 (pt) | inibidores de quinase de tirosina de bruton | |
GB2556856B (en) | Band-Fastened, Convenience-Packaging for storing absorbent personal care articles | |
AR099035A1 (es) | Derivado de 6-oxo-1,6-dihidro-piridazina para usar en el tratamiento de carcinoma de células renales (rcc) | |
PH12016500948A1 (en) | Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib | |
AR093318A1 (es) | Un derivado de 6-oxo-1,6-dihidro-piridazina para el uso para el tratamiento de carcinoma hepatocelular (hcc) | |
MX359110B (es) | Combinacion de un derivado de 6-oxo-1,6-dihidro-piridazina que tiene actividad anticancer con un inhibidor de mek. | |
UY34194A (es) | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? | |
UA98919U (ru) | 4-этил-3-(феноксиметил)-5-((2-((5-феноксиметил)-4-фенил-4н-1,2,4-триазол-3-ил)тио)этил)тио)-4н-1,2,4-триазол, проявляющая диуретическую активность | |
UA88008U (en) | 3-(phenoxymethyl)-5-(propylthio)-1h-1,2,4-triazole exhibiting actoprotector activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |